165 related articles for article (PubMed ID: 29907733)
1. A quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone.
Michalski MN; Williams BO
J Biol Chem; 2018 Jun; 293(24):9542-9543. PubMed ID: 29907733
[TBL] [Abstract][Full Text] [Related]
2. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
Zach F; Polzer F; Mueller A; Gessner A
J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
4. Etiology of Paget's disease and osteoclast abnormalities.
Reddy SV
J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62
Daroszewska A; Rose L; Sarsam N; Charlesworth G; Prior A; Rose K; Ralston SH; van 't Hof RJ
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154079
[TBL] [Abstract][Full Text] [Related]
6. Etiologic factors in Paget's disease of bone.
Reddy SV
Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
[TBL] [Abstract][Full Text] [Related]
7. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
[TBL] [Abstract][Full Text] [Related]
8. Familial Paget's disease of bone: Long-term follow-up of unaffected relatives with and without Sequestosome 1 mutations.
Peeters JJM; De Ridder R; Hamoen EC; Eekhoff EMW; Smit F; Boudin E; Van Hul W; Papapoulos SE; Appelman-Dijkstra NM
Bone; 2019 Nov; 128():115044. PubMed ID: 31449886
[TBL] [Abstract][Full Text] [Related]
9. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
10. Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.
Laurier E; Amiable N; Gagnon E; Brown JP; Michou L
BMC Med Genet; 2017 Nov; 18(1):133. PubMed ID: 29145829
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Paget's disease of bone.
Ralston SH
Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
[TBL] [Abstract][Full Text] [Related]
13. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
14. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
[TBL] [Abstract][Full Text] [Related]
15. Gene-environment interactions in Paget's disease of bone.
Numan MS; Jean S; Dessay M; Gagnon E; Amiable N; Brown JP; Michou L
Joint Bone Spine; 2019 May; 86(3):373-380. PubMed ID: 30594595
[TBL] [Abstract][Full Text] [Related]
16. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
Cronin O; Forsyth L; Goodman K; Lewis SC; Keerie C; Walker A; Porteous M; Cetnarskyj R; Ranganath LR; Selby PL; Hampson G; Chandra R; Ho S; Tobias JH; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia G; Di Stefano M; Guañabens N; Blanch J; Seibel MJ; Walsh JP; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist NL; Boers M; Murray GD; Charnock K; Wilkinson D; Russell RGG; Ralston SH
BMJ Open; 2019 Sep; 9(9):e030689. PubMed ID: 31488492
[TBL] [Abstract][Full Text] [Related]
17. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations.
Bolland MJ; Tong PC; Naot D; Callon KE; Wattie DJ; Gamble GD; Cundy T
J Bone Miner Res; 2007 Mar; 22(3):411-5. PubMed ID: 17181397
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease: epidemiology and pathophysiology.
Seton M
Curr Osteoporos Rep; 2008 Dec; 6(4):125-9. PubMed ID: 19032921
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
[TBL] [Abstract][Full Text] [Related]
20. Molecular effect of an OPTN common variant associated to Paget's disease of bone.
Silva IAL; Conceição N; Gagnon É; Brown JP; Cancela ML; Michou L
PLoS One; 2018; 13(5):e0197543. PubMed ID: 29782529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]